Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10822427
Anti-CSPG4 fusions with interferon for the treatment of malignancy
granted -
US 10813366
Bifidobacterium longum NCIMB 41676
granted -
US 10815285
Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases
granted -
US 10815480
Modulation of alpha synuclein expression
granted -
US 10815483
Compositions for modulating C9ORF72 expression
granted -
US 10808020
Nuclease-mediated regulation of gene expression
granted -
US 10799580
Expression vector delivery system and use thereof for inducing an immune response
granted -
US 10800833
Co-stimulatory domains for use in genetically-modified cells
granted -
US 10799535
Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
granted -
US 10792481
Implantable drug delivery device
granted -
US 10793862
Compositions and methods for modulating growth hormone receptor expression
granted -
US 10793855
Compositions for modulating expression of C9ORF72 antisense transcript
granted -
US 10793865
Transferrable mechanism of generating inducible, BAR domain protein-mediated bacterial outer membrane extensions
granted -
US 10786435
Composition for optical three-dimensional modeling
granted -
US 10788490
Dried cellulose-treated tissue for in-vitro complement activation assays and diagnostic kits
granted -
US 10781242
Interleukin-2 fusion proteins and uses thereof
granted -
US 10774333
Modulators of PNPLA3 expression
granted -
US 10774334
Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
granted -
US 10772906
Modulation of Factor 11 expression
granted -
US 10760076
Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
granted -
US 10758595
Treatment of retinitis pigmentosa using engineered meganucleases
granted -
US 10745702
Compositions and methods for inhibiting expression of the LECT2 gene
granted -
US 10745665
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
granted -
US 10745704
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
granted